Examination of differences between actual and potential revenue generation in a pharmacist-run ambulatory clinic

IF 2.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Journal of the American Pharmacists Association Pub Date : 2024-08-26 DOI:10.1016/j.japh.2024.102223
Emily Van Klompenburg, Amelia Koster, Jacob Ford, Shanna K. O’Connor
{"title":"Examination of differences between actual and potential revenue generation in a pharmacist-run ambulatory clinic","authors":"Emily Van Klompenburg,&nbsp;Amelia Koster,&nbsp;Jacob Ford,&nbsp;Shanna K. O’Connor","doi":"10.1016/j.japh.2024.102223","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Pharmacists are not billable health care providers under Medicare Part B or most insurance plans. Because of this, pharmacist services are relegated to incident-to-provider billing, despite pharmacists routinely providing services high in complexity. This discrepancy may negatively skew perceptions of pharmacists’ contributions to outpatient clinic care.</div></div><div><h3>Objective</h3><div>The objective of this study was to identify the potential revenue generation for pharmacist-delivered services at a single, rural South Dakota clinic if pharmacists were considered billable health care providers.</div></div><div><h3>Methods</h3><div>This retrospective, single center study utilized a chart review of first-quarter data from a single ambulatory clinic served by a 0.5 full time equivalent pharmacist serving Chronic Disease Management (CDM) and COVID-19 patients. For each appointment, the chart note was reviewed for elements that would satisfy requirements for Current Procedural Terminology billing codes. Medicare and Medicaid reimbursement was determined using official 2022 Physician Fee Schedules and private insurance reimbursement was set at a single rate of 60% of the fee schedule of the most common private payer.</div></div><div><h3>Results</h3><div>During the 3-month study period, 118 patients (206 appointments) were seen by the pharmacist. The amount paid to the clinic was estimated at $2174.91. The hypothetical amount paid to the clinic if pharmacists were considered billable health care providers is $10,415.31 for CDM clinic and $7953.48 for COVID-19 clinic, totaling $18,368.79. Excluding uninsured patients, the hypothetical total is $17,102.03, with total unrealized revenue of $16,193.88.</div></div><div><h3>Conclusion</h3><div>If pharmacists were considered billable health care providers and their services were billed accordingly, the potential revenue generation is significantly higher than actually generated revenue. This estimated data can be used to better quantify and qualify appointment-related data for nonpharmacist clinic managers.</div></div>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":"64 6","pages":"Article 102223"},"PeriodicalIF":2.5000,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Pharmacists Association","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1544319124002498","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Pharmacists are not billable health care providers under Medicare Part B or most insurance plans. Because of this, pharmacist services are relegated to incident-to-provider billing, despite pharmacists routinely providing services high in complexity. This discrepancy may negatively skew perceptions of pharmacists’ contributions to outpatient clinic care.

Objective

The objective of this study was to identify the potential revenue generation for pharmacist-delivered services at a single, rural South Dakota clinic if pharmacists were considered billable health care providers.

Methods

This retrospective, single center study utilized a chart review of first-quarter data from a single ambulatory clinic served by a 0.5 full time equivalent pharmacist serving Chronic Disease Management (CDM) and COVID-19 patients. For each appointment, the chart note was reviewed for elements that would satisfy requirements for Current Procedural Terminology billing codes. Medicare and Medicaid reimbursement was determined using official 2022 Physician Fee Schedules and private insurance reimbursement was set at a single rate of 60% of the fee schedule of the most common private payer.

Results

During the 3-month study period, 118 patients (206 appointments) were seen by the pharmacist. The amount paid to the clinic was estimated at $2174.91. The hypothetical amount paid to the clinic if pharmacists were considered billable health care providers is $10,415.31 for CDM clinic and $7953.48 for COVID-19 clinic, totaling $18,368.79. Excluding uninsured patients, the hypothetical total is $17,102.03, with total unrealized revenue of $16,193.88.

Conclusion

If pharmacists were considered billable health care providers and their services were billed accordingly, the potential revenue generation is significantly higher than actually generated revenue. This estimated data can be used to better quantify and qualify appointment-related data for nonpharmacist clinic managers.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
研究药剂师经营的非住院诊所实际创收与潜在创收之间的差异。
背景:在医疗保险 B 部分或大多数保险计划中,药剂师都不属于计费医疗服务提供者。正因如此,尽管药剂师经常提供复杂性较高的服务,但药剂师的服务却被归类为 "事件到提供者"(incident-to-provider billing)。这种差异可能会对药剂师对门诊护理的贡献产生负面影响:本研究旨在确定,如果药剂师被视为可计费的医疗服务提供者,那么药剂师在南达科他州一家农村诊所提供的服务可能产生的收入:这项回顾性的单中心研究利用了对一家门诊诊所第一季度数据的病历审查,该诊所有一名相当于 0.5 个全职药剂师的药剂师为慢性病管理 (CDM) 和 COVID-19 患者提供服务。对每次预约的病历记录都进行了审查,以确定是否符合当前程序术语 (CPT®) 账单代码的要求。医疗保险和医疗补助的报销额度是根据 2022 年的官方医生收费表确定的,私人保险的报销额度则设定为最常见私人付款人收费表的 60% 的单一费率:在为期三个月的研究期间,药剂师共为 118 名患者(206 次预约)提供了服务。支付给诊所的金额估计为 2,174.91 美元。如果将药剂师视为收费医疗服务提供者,则 CDM 诊所支付的假设金额为 10,415.31 美元,COVID-19 诊所支付的假设金额为 7,953.48 美元,共计 18,368.79 美元。如果不包括未参保患者,假设总额为 17 102.03 美元,未实现收入总额为 16 193.88 美元:如果将药剂师视为应收费的医疗服务提供者,并对其服务进行相应收费,那么潜在的创收将大大高于实际创收。这一估算数据可用于更好地量化和限定非药剂师诊所管理人员的预约相关数据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.30
自引率
14.30%
发文量
336
审稿时长
46 days
期刊介绍: The Journal of the American Pharmacists Association is the official peer-reviewed journal of the American Pharmacists Association (APhA), providing information on pharmaceutical care, drug therapy, diseases and other health issues, trends in pharmacy practice and therapeutics, informed opinion, and original research. JAPhA publishes original research, reviews, experiences, and opinion articles that link science to contemporary pharmacy practice to improve patient care.
期刊最新文献
Implementing a Telemedicine-led Heart Failure Medication Regimen Optimization Clinic in Medically Underserved Heart Failure Populations. Exploring the pharmacist role in insomnia management and care provision: A scoping review. Long-Term Opioid Therapy in Older Adults: Incidence and Risk Factors Related to Patient Characteristics and Initial Opioid Dispensed. Pharmacists Enhance National Security through Medical Countermeasure Program Leadership. Barriers to and Facilitators of Buprenorphine Dispensing for Opioid Use Disorder: Evidence from Focus Groups in Appalachian Kentucky.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1